Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: This is a spontaneous report from a contactable consumer received from the Regulatory Authority products Regulatory Agency (UK-MHRA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106041211190630-1KAGO. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jun2021 (as reported) (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included suppressed lactation, and suspected covid-19 from 03May2020 to 10Jun2020. Patient was not enrolled in clinical trial. Patient was not pregnant. Patient was not currently breastfeeding. The patient''s concomitant medications were not reported. Day of vaccine- 03Jun2021 (as reported). The patient experienced small headache in evening (approx. 4 hours after), sleepless and restless, pain in site of injection, day after fever, hot nausea all day, stomach discomfort, dizzy/woozy, pressure headache and blurred eyesight. The patient experienced nausea on 04Jun2021. The patient underwent lab tests and procedures which included COVID-19 virus test: inconclusive test on an unspecified date. The outcome of events nausea, headache, dizziness and injection site pain was not recovered, of other events was unknown. This is a serious report received with serious criteria medically significant from . No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166